{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:32:33Z","timestamp":1787668353171,"version":"build-2736575974"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"The Key Laboratory of Traditional Chinese Medicine Arthritis Diagnosis and Treatment Research in Zhejiang Zhejiang Province","award":["A-2023-W2008"],"award-info":[{"award-number":["A-2023-W2008"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>So far cases of rheumatoid arthritis (RA) complicated with myasthenia gravis (MG) are rare in reports, and specific treatment measures remain unclear. Therefore, this paper presents a case of a 57-year-old female patient with a history of MG who currently has rheumatoid arthritis. After conventional treatment failed, the patient started subcutaneous injection of telitacicept, which led to rapid and sustained clinical improvement. This is the first report on the treatment of RA complicated with MG by telitacicept. Meanwhile, the application of telitacicept in the treatment of this disease deserves further research and attention.<\/jats:p>","DOI":"10.1093\/mrcr\/rxaf074","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T12:28:46Z","timestamp":1762777726000},"source":"Crossref","is-referenced-by-count":2,"title":["Successful treatment of rheumatoid arthritis complicated with myasthenia gravis by telitacicept: a case report"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0983-9206","authenticated-orcid":false,"given":"Sheng","family":"Qiu","sequence":"first","affiliation":[{"name":"The Second School of Clinical Medicine, Zhejiang Chinese Medical University , Zhejiang ,","place":["China"]},{"name":"Department of Rheumatology and Immunology, Center for General Practice Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College) , Zhejiang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5443-3675","authenticated-orcid":false,"given":"Zhenhua","family":"Ying","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Center for General Practice Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College) , Zhejiang ,","place":["China"]},{"name":"Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine Cultivation for Arthritis Diagnosis and Treatment , Zhejiang ,","place":["China"]},{"name":"Rheumatology and Immunology Research Institute, Hangzhou Medical College , No. 158, Shangtang Road, Hangzhou City, Zhejiang Province ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"2025112810273123300_ref1","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet."},{"key":"2025112810273123300_ref2","doi-asserted-by":"crossref","first-page":"101742","DOI":"10.1016\/j.berh.2022.101742","article-title":"Precision medicine in rheumatoid arthritis","volume":"36","author":"Bhamidipati","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2025112810273123300_ref3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3390\/cells9040880","article-title":"Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis","volume":"9","author":"Lin","year":"2020","journal-title":"Cells."},{"key":"2025112810273123300_ref4","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1007\/s10067-023-06628-2","article-title":"Estimation of the global prevalence, incidence, years lived with disability of rheumatoid arthritis in 2019 and forecasted incidence in 2040: results from the global burden of disease study 2019","volume":"42","author":"Shi","year":"2023","journal-title":"Clin Rheumatol"},{"key":"2025112810273123300_ref5","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s10067-022-06062-w","article-title":"Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options","volume":"41","author":"Bixio","year":"2022","journal-title":"Clin Rheumatol"},{"key":"2025112810273123300_ref6","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00296-020-04587-4","article-title":"Adalimumab-induced myasthenia gravis: case-based review","volume":"40","author":"Pelechas","year":"2020","journal-title":"Rheumatol Int"},{"key":"2025112810273123300_ref7","doi-asserted-by":"crossref","first-page":"1400459","DOI":"10.3389\/fimmu.2024.1400459","article-title":"Case report: a highly active refractory myasthenia gravis with treatment of telitacicept combined with efgartigimod","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Immunol"},{"key":"2025112810273123300_ref8","doi-asserted-by":"crossref","first-page":"17562864241251476","DOI":"10.1177\/17562864241251476","article-title":"Effectiveness and safety of telitacicept for refractory generalized myasthenia gravis: a retrospective study","volume":"17","author":"Lin","year":"2024","journal-title":"Ther Adv Neurol Disord"},{"key":"2025112810273123300_ref9","doi-asserted-by":"crossref","first-page":"e16322","DOI":"10.1111\/ene.16322","article-title":"A multicenter, randomized, open-label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis","volume":"31","author":"Yin","year":"2024","journal-title":"Eur J Neurol"},{"key":"2025112810273123300_ref10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/bcp.12908","article-title":"Pharmacokinetics, pharmacodynamics, short term efficacy and safety of RCT-18, a novel BLyS\/APRIL fusion protein, in patients with rheumatoid arthritis","volume":"82","author":"Chen","year":"2016","journal-title":"Br J Clin Pharmacol"}],"container-title":["Modern Rheumatology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mrcr\/advance-article-pdf\/doi\/10.1093\/mrcr\/rxaf074\/65269195\/rxaf074.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/9\/2\/rxaf074\/65269195\/rxaf074.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mrcr\/article-pdf\/9\/2\/rxaf074\/65269195\/rxaf074.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T15:27:38Z","timestamp":1764343658000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mrcr\/article\/doi\/10.1093\/mrcr\/rxaf074\/8320491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7,25]]}},"URL":"https:\/\/doi.org\/10.1093\/mrcr\/rxaf074","relation":{},"ISSN":["2472-5625"],"issn-type":[{"value":"2472-5625","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"rxaf074"}}